GPS Wealth Strategies Group’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-8
Closed -$162 1246
2023
Q3
$162 Hold
8
﹤0.01% 1249
2023
Q2
$204 Hold
8
﹤0.01% 1216
2023
Q1
$238 Buy
+8
New +$232 ﹤0.01% 1219
2022
Q4
Sell
-8
Closed 178
2022
Q3
$0 Hold
8
﹤0.01% 1126
2022
Q2
$0 Hold
8
﹤0.01% 1103
2022
Q1
$0 Sell
8
-258
-97% -$8.31K ﹤0.01% 1038
2021
Q4
$9K Hold
266
﹤0.01% 747
2021
Q3
$8K Hold
266
﹤0.01% 750
2021
Q2
$10K Hold
266
﹤0.01% 723
2021
Q1
$11K Buy
+266
New +$12.5K ﹤0.01% 653

Other funds holding AVNS

GPS Wealth Strategies Group's AVNS Position: Q4 2023 in Review

GPS Wealth Strategies Group sold out of Avanos Medical (AVNS) in Q4 2023, closing a stake of 8 shares — an estimated $162 sold.

GPS Wealth Strategies Group first reported a position in AVNS in Q1 2021 and held it in 10 quarters. The position peaked at $11K in Q1 2021. 265 funds tracked by Wall St. Rank hold AVNS as of Q4 2023.

  • GPS Wealth Strategies Group reported no remaining Avanos Medical position as of Q4 2023 after selling out during the quarter.
  • GPS Wealth Strategies Group sold 8 Avanos Medical shares in Q4 2023, an estimated $162.
  • GPS Wealth Strategies Group first reported a position in Avanos Medical in Q1 2021 and held it in 10 quarters.
  • GPS Wealth Strategies Group's Avanos Medical position peaked at $11K in Q1 2021.
  • 265 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2023.

Based on GPS Wealth Strategies Group's 13F filing for Q4 2023, filed 12 Jan 2024.